News

conference

Apr 23, 2023

2023 - AACR - SQ3370 Poster

SQ3370, a doxorubicin-based click chemistry therapeutic, promotes a shift from an immunosuppressive towards a T-cell permissive tumor microenvironment in patients

conference

Apr 23, 2023

2023 - AACR - SQP22 Poster

A click chemistry-activated auristatin protodrug (SQP22) demonstrates potency and safety with antibody and intratumoral tumor-targeting agents

conference

Apr 16, 2023

2023 AACR

CAPAC a modular platform that can improve the safety and efficacy of existing cancer therapies

media

Apr 1, 2023

Drug Discovery World

The Nobel Prize winning power of click chemistry

publication

Mar 29, 2023

Pre print

SQ3370, the first clinical click chemistry-activated cancer therapeutic, shows safety in humans and translatability across species

media

Mar 1, 2023

Pharma's Almanac

What do you view as the most disruptive or transformational technology or development on the horizon?

media

Mar 1, 2023

Life Science Leader

Translating Nobel Prize Winning Science Into Medicine

media

Feb 8, 2023

The Bio Report

A Company That Bets Its Therapies Will Click with Patients

media

Jan 12, 2023

Healio

Nobel laureate takes pride in success of bioorthogonal chemistry for cancer treatment

media

Dec 2, 2022

SF Business Times

The Long Game, Nobel Prize winners pay it forward

conference

Nov 7, 2022

2022 - SITC - SQ3370 Poster

Treatment with SQ3370, a doxorubicin-based click chemistry therapeutic, promotes immune activation in the tumor microenvironment

conference

Nov 7, 2022

2022 - SITC - SQ2270 Poster

SQ2270, a Novel MMAE-based Click Chemistry Therapeutic, Promotes Tumor Growth Inhibition and Extensive Immune Cell Infiltration in the RENCA Cancer Model